On 2025-11-10, ArriVent BioPharma, Inc. (AVBP) announced earnings per share of $-0.83 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-0.78.
The next expected annoucement date for quarterly earnings is 2026-03-02, with an average estimated earnings per share of $-0.84 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-10 | 2025-09-30 | $-0.78 | $-0.83 |
| 2025-08-11 | 2025-06-30 | $-0.70 | $-0.90 |
| 2025-05-12 | 2025-03-31 | $-0.66 | $-1.90 |
| 2025-03-03 | 2024-12-31 | $-0.78 | $-0.60 |
| 2024-11-14 | 2024-09-30 | $-0.82 | $-0.61 |
| 2024-08-14 | 2024-06-30 | $-0.65 | $-0.65 |
| 2024-05-08 | 2024-03-31 | $-0.84 | $-0.70 |